Clinical Trial Update: Safety and Efficacy Evaluation of IM19 CAR-T Cells [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on the safety and efficacy evaluation of IM19 CAR-T Cells in leukemia across Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• IM19 CAR-T Cells

Snippet

Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd. | Conditions: Leukemia | Phase 1, Phase 2 | Status: UNKNOWN